SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001068238-23-000251
Filing Date
2023-12-26
Accepted
2023-12-26 16:25:31
Documents
1

Document Format Files

Seq Description Document Type Size
1 GKCC SCHEDULE 13D/A gkcc_schedule13d.htm SC 13D/A 75271
  Complete submission text file 0001068238-23-000251.txt   76903
Mailing Address 451 D STREET, 5TH FLOOR BOSTON MA 02210
Business Address 451 D STREET, 5TH FLOOR BOSTON MA 02210 (857) 209-0050
Elicio Therapeutics, Inc. (Subject) CIK: 0001601485 (see all company filings)

IRS No.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-93548 | Film No.: 231513603
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 501 SILVERSIDE ROAD SUITE 87AVA WILMINGTON DE 19809
Business Address 501 SILVERSIDE ROAD SUITE 87AVA WILMINGTON DE 19809 (302) 992-8882
GKCC, LLC (Filed by) CIK: 0001977769 (see all company filings)

IRS No.: 472175589 | State of Incorp.: DE
Type: SC 13D/A